High-dose infliximab for treatment of pediatric ulcerative colitis: A survey of clinical practice Academic Article uri icon

Overview

MeSH Major

  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Colitis, Ulcerative
  • Gastrointestinal Agents

abstract

  • IFX 10 mg/kg is more commonly used in the United States to treat pediatric UC. Efficacy and safety data are required to avoid insurance barriers for its use.

publication date

  • March 21, 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC3309912

Digital Object Identifier (DOI)

  • 10.3748/wjg.v18.i11.1229

PubMed ID

  • 22468086

Additional Document Info

start page

  • 1229

end page

  • 34

volume

  • 18

number

  • 11